Mechanisms of Mycophenolic Acid-Induced Gastrointestinal Toxicity and Potential Therapeutic Interventions in Primary Mouse Colonic Organoids

dc.contributor.advisorGreenway, Steven
dc.contributor.authorMack-Bowles, Brenan
dc.contributor.committeememberHirota, Simon
dc.contributor.committeememberLewis, Ian
dc.date2024-11
dc.date.accessioned2024-09-19T20:03:19Z
dc.date.available2024-09-19T20:03:19Z
dc.date.issued2024-09-17
dc.description.abstractMycophenolate Mofetil (MMF) is a commonly prescribed immunosuppressant that demonstrates important clinical relevance. However, MMF therapy is linked to frequent gastrointestinal (GI) side effects that limit its use. Little is known about the mechanisms underlying MMF-induced GI injury. Using a primary mouse colon organoid model, we have found that mycophenolic acid (MPA), the pharmacologically active metabolite of MMF, significantly alters intestinal barrier function and permeability through modulation of tight junctions. RNA sequencing revealed that MPA significantly disrupted pathways related to cell cycle regulation, DNA replication, cytoskeleton dynamics, and suppression of senescence. MPA was observed to significantly reduce cellular proliferation, which was ameliorated through guanosine supplementation. Addition of exogenous guanosine was also observed to significantly restore barrier function back to control levels. The guanosine studies presented in this thesis suggest MPA’s inhibition of nucleotide metabolism is not selective for lymphocytes but is broader than originally described. This work represents one of the first investigations of MPA using a colon organoid model, providing critical insights into the intracellular mechanisms of MPA-induced GI toxicity.
dc.identifier.citationMack-Bowles, B. (2024). Mechanisms of mycophenolic acid-induced gastrointestinal toxicity and potential therapeutic interventions in primary mouse colonic organoids (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca.
dc.identifier.urihttps://hdl.handle.net/1880/119819
dc.language.isoen
dc.publisher.facultyGraduate Studies
dc.publisher.institutionUniversity of Calgary
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
dc.subjectMycophenolate mofetil
dc.subjectMycophenolic acid
dc.subjectImmunosuppressive therapy
dc.subjectCell culture
dc.subjectOrganoids
dc.subjectGastrointestinal toxicity
dc.subjectColonoid culture
dc.subjectIntestinal barrier function
dc.subjectTransepithelial resistance
dc.subjectFITC-dextran permeability
dc.subjectTotal RNA-sequencing
dc.subjectGuanosine supplementation
dc.subjectIngenuity Pathway Analysis
dc.subjectColonoid monolayer culture
dc.subject.classificationPhysiology
dc.subject.classificationBiology--Cell
dc.subject.classificationBiology--Molecular
dc.subject.classificationPharmacology
dc.subject.classificationImmunology
dc.titleMechanisms of Mycophenolic Acid-Induced Gastrointestinal Toxicity and Potential Therapeutic Interventions in Primary Mouse Colonic Organoids
dc.typemaster thesis
thesis.degree.disciplineMedicine – Medical Sciences
thesis.degree.grantorUniversity of Calgary
thesis.degree.nameMaster of Science (MSc)
ucalgary.thesis.accesssetbystudentI do not require a thesis withhold – my thesis will have open access and can be viewed and downloaded publicly as soon as possible.
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ucalgary_2024_mack-bowles_brenan.pdf
Size:
3.63 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.62 KB
Format:
Item-specific license agreed upon to submission
Description: